Kevin D. Lustig

8.5k citations

26 papers · 7.2k indexed · 5 hit papers · h-index 21

Molecular Biology top 1%
Surgery top 0.5%
Oncology top 0.5%
Epidemiology top 5%
Physiology top 0.2%

Co-authors: David J. Mangelsdorf Joyce J. Repa Bei Shan Hua Tu David Julius Julio C. Medina R. Marc Learned Mitchell Hull
Topics: Adenosine and Purinergic Signaling (9 papers)RNA Interference and Gene Delivery (4 papers)Developmental Biology and Gene Regulation (4 papers)
Cited by: Physiology Oncology Surgery
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States United Kingdom Israel

In The Last Decade

Kevin D. Lustig

25 papers receiving 7.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Nuclear Receptor for Bile Acids

1999 2.2k citations Makoto Makishima, Joyce J. Repa et al. Science profile →
Role of LXRs in control of lipogenesis

2000 1.4k citations Joshua R. Schultz, Hua Tu et al. Genes & Development profile →
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers

2000 1.1k citations Joyce J. Repa, S D Turley et al. Science profile →
Substitution of three amino acids switches receptor specificity of Gqα to that of Giα

1993 626 citations Bruce R. Conklin, Zvi Farfel et al. Nature profile →
Expression cloning of an ATP receptor from mouse neuroblastoma cells.

1993 506 citations Kevin D. Lustig, Andrew K. Shiau et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Kevin D. Lustig

Since Specialization

Citations

This map shows the geographic impact of Kevin D. Lustig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin D. Lustig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin D. Lustig more than expected).

Fields of papers citing papers by Kevin D. Lustig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin D. Lustig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin D. Lustig. The network helps show where Kevin D. Lustig may publish in the future.

Co-authorship network of co-authors of Kevin D. Lustig

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin D. Lustig. A scholar is included among the top collaborators of Kevin D. Lustig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin D. Lustig. Kevin D. Lustig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	α-Mercaptoketone based histone deacetylase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Paul L. Wash,Timothy Z. Hoffman,Brandon M. Wiley,Céline Bonnefous,Nicholas D. Smith,(unknown),C. Martin Lawrence,Kent T. Symons,(unknown),Kevin D. Lustig,Xin Guo,Tami Annable,Stewart A. Noble,Jeffrey H. Hager,Christian A. Hassig,James W. Malecha	7
2	P2U Purinoceptors: cDNA Cloning, Signal Transduction Mechanisms and Structure–Function Analysis 2007 ·Novartis Foundation symposium ·Kevin D. Lustig,Gary A. Weisman,John T. Turner,Richard C. Garrad,Andrew K. Shiau,Laurie Erb	0
3	Role of LXRs in control of lipogenesisbreakdown → 2000 ·Genes & Development ·Joshua R. Schultz,Hua Tu,(unknown),Joyce J. Repa,Julio C. Medina,Leping Li,Susan W. Schwendner,Shelley Wang,Martin Thoolen,David J. Mangelsdorf,Kevin D. Lustig,Bei Shan	1394
4	Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimersbreakdown → 2000 ·Science ·Joyce J. Repa,S D Turley,Jean Marc Lobaccaro,Julio C. Medina,(unknown),Kevin D. Lustig,B Shan,Richard A. Heyman,John M. Dietschy,David J. Mangelsdorf	1087
5	Identification of a Nuclear Receptor for Bile Acidsbreakdown → 1999 ·Science ·Makoto Makishima,(unknown),Joyce J. Repa,Hua Tu,R. Marc Learned,(unknown),Mitchell Hull,Kevin D. Lustig,David J. Mangelsdorf,Bei Shan	2206
6	Systematic identification of mitotic phosphoproteins 1997 ·Current Biology ·P. Todd Stukenberg,Kevin D. Lustig,Thomas J. McGarry,Randall W. King,Jian Kuang,Marc W. Kirschner	207
7	Specific Proteolysis of the Kinase Protein Kinase C-related Kinase 2 by Caspase-3 during Apoptosis 1997 ·Journal of Biological Chemistry ·Vincent L. Cryns,Young-Sup Byun,Ajay Rana,(unknown),Kevin D. Lustig,Louis R. Ghanem,Peter J. Parker,Marc W. Kirschner,Junying Yuan	92
8	Small pool expression screening: Identification of genes involved in cell cycle control, apoptosis, and early development 1997 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Kevin D. Lustig,P. Todd Stukenberg,Thomas J. McGarry,Randall W. King,Vincent L. Cryns,Paul E. Mead,Leonard I. Zon,Junying Yuan,Marc W. Kirschner	63
9	Expression cloning of a Xenopus T-related gene (Xombi) involved in mesodermal patterning and blastopore lip formation 1996 ·Development ·Kevin D. Lustig,Kristen L. Kroll,Edna E. Sun,Marc W. Kirschner	190
10	A Xenopus nodal-related gene that acts in synergy with noggin to induce complete secondary axis and notochord formation 1996 ·Development ·Kevin D. Lustig,Kristen L. Kroll,Edna E. Sun,Ricardo Guelerman Pinheiro Ramos,Heidi G. Elmendorf,Marc W. Kirschner	101
11	Substitution of three amino acids switches receptor specificity of Gqα to that of Giαbreakdown → 1993 ·Nature ·Bruce R. Conklin,Zvi Farfel,Kevin D. Lustig,David Julius,Henry R. Bourne	626
12	Signal Transduction Pathways Coupled to a P_2U Receptor in Neuroblastoma × Glioma (NG108‐15) Cells 1993 ·Journal of Neurochemistry ·T.A. Lin,Kevin D. Lustig,(unknown),Gary A. Weisman,Grace Y. Sun	60
13	Extracellular ATP Reversibly Increases the Plasma Membrane Permeability of Transformed Mouse Fibroblasts to Large Macromolecules 1993 ·Analytical Biochemistry ·A. Sami Sarıbaş,Kevin D. Lustig,(unknown),Gary A. Weisman	23
14	Functional expression and photoaffinity labeling of a cloned P2U purinergic receptor. 1993 ·Proceedings of the National Academy of Sciences ·Laurie Erb,Kevin D. Lustig,Daniel Sullivan,John T. Turner,Gary A. Weisman	91
15	Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells 1992 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Kevin D. Lustig,Laurie Erb,(unknown),(unknown),Xiaoke Zhang,(unknown),Gary A. Weisman	66
16	Detection of Coincident Signals by G Proteins and Adenylyl Cyclase 1992 ·Cold Spring Harbor Symposia on Quantitative Biology ·Henry R. Bourne,Kevin D. Lustig,Yung Hou Wong,Bruce R. Conklin	4
17	A nucleotide receptor in vascular endothelial cells is specifically activated by the fully ionized forms of ATP and UTP 1992 ·Biochemical Journal ·Kevin D. Lustig,(unknown),Laurie Erb,Gary A. Weisman	52
18	Covalent incorporation of 3'-O-(4-benzoyl)benzoyl-ATP into a P2 purinoceptor in transformed mouse fibroblasts. 1990 ·Journal of Biological Chemistry ·Laurie Erb,Kevin D. Lustig,Asraa Ahmed,Fernando A. González,Gary A. Weisman	53
19	Permeabilization of transformed mouse fibroblasts by 3′‐O‐(4‐benzoyl)benzoyl adenosine 5′‐triphosphate and the desensitization of the process 1989 ·Journal of Cellular Physiology ·Fernando A. González,Ahmed H. Ahmed,Kevin D. Lustig,Laurie Erb,Gary A. Weisman	43
20	Growth inhibition of transformed mouse fibroblasts by adenine nucleotides occurs via generation of extracellular adenosine. 1988 ·Journal of Biological Chemistry ·Gary A. Weisman,Kevin D. Lustig,(unknown),(unknown),Ilana Belzer,Ilan Friedberg	67

About Kevin D. Lustig

Kevin D. Lustig is a scholar working on Physiology, Molecular Biology and Biochemistry, having authored 26 papers that have together received 7.2k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (9 papers), RNA Interference and Gene Delivery (4 papers) and Developmental Biology and Gene Regulation (4 papers). The work is most often cited by research in Physiology (885 citations), Oncology (2.7k citations) and Surgery (3.1k citations). Kevin D. Lustig has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include David J. Mangelsdorf, Joyce J. Repa, Bei Shan, Hua Tu, David Julius, Julio C. Medina, R. Marc Learned, Mitchell Hull, Makoto Makishima and Henry R. Bourne. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact